Congenital Amegakaryocytic Thrombocytopenia
Also known as: CAT, CAMT
What is congenital amegakaryocytic thrombocytopenia?
Megakaryocytes are formed in the bone marrow from an early stem cell, and they, through a complex process produce platelets which play a very important role in blood clotting and the prevention of bleeding. CAT is a rare disorder (two types) found in infants where there are very few megakaryocytes and platelets in bone marrow
, and while initially the bone marrow produces red and white cells this eventually decreases /stops so the baby/child has a lack of platelets, red cells and white cells. Children with CAT may be at risk for other bone marrow diseases.
What causes congenital amegakaryocytic thrombocytopenia?
CAT is an inherited congenital disorder (babies are born with it) caused by mutations (changes) in a specific gene.
What are the signs/ symptoms of congenital amegakaryocytic thrombocytopenia?
Children with CAT tend to bruise easily, can experience life-threatening bleeding or have tiny red dots under the skin from bleeding (called petechiae). They may also have abnormalities of brain function, heart problems and other malformations.
What are congenital amegakaryocytic thrombocytopenia care options?
Children with CAT frequently need blood transfusions. A stem cell transplant can cure the disease in some patients..
Reviewed by: Jack Wolfsdorf, MD, FAAP
This page was last updated on: 5/23/2018 10:32:37 AM
Camp U.O.T.S. is an annual weeklong, overnight camp for children with cancer and blood disorders who are treated at Nicklaus Children’s Hospital.
Learn more and register
From the Newsdesk
More than two dozen children attended the Bear Hug camp at Nicklaus Children's last week. This day camp is for siblings of pediatric cancer patients to encourage socialization among peers and help them gain insight on their siblings' care journey.
On this very same day nine years ago, Daniella Alvarez was diagnosed Teratoid Rhabdoid Tumor (ATRT), a rare and aggressive type of brain cancer. The news came on June 26, 2009, her second birthday. Daniella endured years of brain surgeries, aggressive chemotherapies, radiation, imaging scans, multiple visits to intensive care at Nicklaus Children’s Hospital. She is now cancer free thanks to a pediatric clinical trial made possible through research funding.
At a young age, Bi’Yanie was diagnosed with sickle cell, a blood disorder that causes the cells to take on a crescent or sickle shape and can lead to very painful episodes called crises. Today, Bi’Yanie is getting stronger by the day, thanks to the bone marrow transplant she received at Nicklaus Children’s Hospital.